LL
Therapeutic Areas
HT BioImaging Pipeline
| Drug | Indication | Phase |
|---|---|---|
| HDI Oral Cancer Scanner | Oral Squamous Cell Carcinoma | 510(k) cleared |
| HDI Cervical Cancer Detector | Cervical Cancer | Preclinical |
| HDI Skin Cancer Detector | Cutaneous Melanoma & Non‑Melanoma Skin Cancers | Preclinical |
| HDI Prostate Cancer Detector | Prostate Cancer | Preclinical |
| HDI Colon Cancer Detector | Colorectal Cancer | Preclinical |
| HDI Intra‑operative Margin Mapping | Surgical Oncology | Preclinical |
| HT Vista Veterinary Cancer Screen | Subcutaneous/Dermal Tumors in Dogs & Cats | Clinical Validation Completed |
Leadership Team at HT BioImaging
ST
Shani Toledano
Co‑Founder & CEO
GB
Gideon Barak
Co‑Founder & Chairman
SG
Sharon Gat, PhD
Chief Scientific Officer
MT
Moshe Tshuva, PhD
Chief Veterinary Officer
GP
Gabriel Polliack, MD MHA
Chief Medical Officer
TD
Tal Dembinsky
Clinical Education Lead
MB
Marlen Ben David
VP R&D